DOCSLIB.ORG

Suppression of DNA-Damage Checkpoint Signaling by Rsk-Mediated Phosphorylation of Mre11

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Suppression of DNA-Damage Checkpoint Signaling by Rsk-Mediated Phosphorylation of Mre11 Suppression of DNA-damage checkpoint signaling by Rsk-mediated phosphorylation of Mre11 Chen Chen, Liguo Zhang, Nai-Jia Huang, Bofu Huang, and Sally Kornbluth1 Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710 Edited by Tony Hunter, The Salk Institute for Biological Studies, La Jolla, CA, and approved November 12, 2013 (received for review April 9, 2013) Ataxia telangiectasia mutant (ATM) is an S/T-Q–directed kinase A hallmark of cancer cells is their ability to override cell-cycle that is critical for the cellular response to double-stranded breaks checkpoints, including the DSB checkpoint, which arrests the cell (DSBs) in DNA. Following DNA damage, ATM is activated and cycle to allow adequate time for damage repair. Previous studies recruited by the MRN protein complex [meiotic recombination 11 have implicated the MAPK pathway in inhibition of DNA-dam- (Mre11)/DNA repair protein Rad50/Nijmegen breakage syndrome age signaling: PKC suppresses DSB-induced G2/M checkpoint 1 proteins] to sites of DNA damage where ATM phosphorylates signaling following ionizing radiation via activation of ERK1/2 multiple substrates to trigger cell-cycle arrest. In cancer cells, this (22); activation of RAF kinase, leading to activation of MEK/ regulation may be faulty, and cell division may proceed even in ERK/Rsk, also can suppress G2/M checkpoint signaling (23). the presence of damaged DNA. We show here that the ribosomal Given its prominent role in multiple cancers, the MAPK s6 kinase (Rsk), often elevated in cancers, can suppress DSB-induced pathway is an attractive therapeutic target. Indeed, treatment of melanoma using the RAF inhibitor vemurafenib has shown some ATM activation in both Xenopus egg extracts and human tumor cell clinical success, as has treatment of nonsmall cell lung carcinoma lines. In analyzing each step in ATM activation, we have found that with MEK inhibitors (24). However, targeting components at the Rsk targets loading of MRN complex components onto DNA at DSB apex of a signaling pathway may induce side effects caused by the sites. Rsk can phosphorylate the Mre11 protein directly at S676 both plethora of downstream effectors (25, 26). As a terminal kinase in vitro and in intact cells and thereby can inhibit the binding of in the MAPK pathway, Rsk may avoid these complications as Mre11 to DNA with DSBs. Accordingly, mutation of S676 to Ala can a potential target. Thus, there has been interest in targeting Rsk reverse inhibition of the response to DSBs by Rsk. Collectively, these for cancers with notable Rsk elevation (e.g., prostate cancers) (27). data point to Mre11 as an important locus of Rsk-mediated check- Several Rsk-specific inhibitors have been described, including point inhibition acting upstream of ATM activation. SL0101 and BI-D1870 (18, 28, 29). Whether these or derivative drugs will be clinically successful remains unclear. However, if Rsk dsDNA IP | PMA | SL0101 | γ-H2AX inhibition can reinstate DSB-induced checkpoint function, then combination therapy of Rsk inhibitors with DNA-damaging agents ells have evolved multiple pathways signaling DNA damage may be effective in inducing tumor cell arrest or death. Cthat trigger DNA repair, cell-cycle arrest and, in the event The precise mechanism underlying checkpoint inhibition down- of irreparable damage, cell death. Among the various forms of stream of MEK/ERK/Rsk signaling is not yet clear. One recent DNA damage, double-stranded breaks (DSBs) in DNA, gener- paper has shown that, after doxorubicin-induced DNA damage (both DSB and ssDNA breaks), Rsk can silence the G2/M ated by exposure to ionizing radiation and radiomimetic chemicals checkpoint by phosphorylating (and inhibiting) the Chk1 kinase such as neocarzinostatin (NCS), are the most lethal for cells (1). on S280 (the same site that can be targeted by protein kinase B/ DSBs often are repaired by homologous recombination during Akt kinase) (30). However, another group has reported that the S and G2/M phases of the cell cycle, which involves the phosphorylation of this site on Chk1 enhanced its ability to en- meiotic recombination 11 (Mre11)/DNA repair protein Rad50/ force the checkpoint by promoting its nuclear translocation (31). Nijmegen breakage syndrome 1 (Nbs1) (MRN) complex and the We show here that Rsk signaling silences the DSB-induced ataxia telangiectasia mutated (ATM) kinase (2, 3). The MRN fi G2/M checkpoint by preventing activation of the ATM kinase. complex rst recognizes sites of DNA damage and then pro- Specifically, we have found that Rsk targets the Mre11 compo- motes binding of ATM to the DSB site. ATM, activated by nent of the MRN complex by phosphorylating S676, thereby monomerization and autophosphorylation, phosphorylates down- preventing Mre11 binding to DNA. Mutation of S676 restored stream proteins including p53, checkpoint kinase 2 (Chk2), and ATM activation, even in the face of high Rsk activity, and rendered breast cancer 1, early onset (BRCA1) (4-7). These factors then convey the signal to induce cycle arrest, apoptosis, or DNA repair Significance (8). Failure of this process results in genome instability, increasing the risk of cancer, neurodegeneration, and other pathologies (9). CELL BIOLOGY Ribosomal S6 kinase (Rsk), which functions downstream of We have identified a pathway that links MAPK/ribosomal s6 mitogen-activated protein kinase kinase (MEK) and ERK, is kinase (Rsk) signaling to the inhibition of the response to frequently activated in cancer cells (10, 11). Rsk activation can a double-stranded break (DSB) in DNA, potentially explaining be promoted by multiple signaling pathways in cancer cells, in- radioresistance in tumors with high rapidly accelerated fibro- cluding those triggered by steroids, insulin, EGF, and estrogen sarcoma (Raf)/MAPK/Rsk activity. The locus of this regulation (10, 12–15). Additionally, Rsk activation can be triggered by was identified as meiotic recombination 11, whose phosphor- PKC signaling [via the PKC/rapidly accelerated fibrosarcoma ylation by Rsk prevented its DNA binding and consequent ac- (RAF)/mitogen-activated protein kinases (MAPK) pathway], tivation of the central DSB checkpoint regulator, ataxia which is activated by phorbol12-myristate13-acetate (PMA) (16, telangiectasia mutant. 17). Previous studies have found that Rsk2 is overexpressed in 50% of breast cancers and prostate tumors (18, 19), and Rsk Author contributions: C.C. and S.K. designed research; C.C., L.Z., N.-J.H., and B.H. per- signaling has been implicated in the regulation of survival, an- formed research; C.C. analyzed data; and C.C. and S.K. wrote the paper. chorage-independent growth, and transformation of breast cancer The authors declare no conflict of interest. cells in culture (20). Rsk-specific inhibition (with BI-D1870 or This article is a PNAS Direct Submission. SL0101) significantly reduced proliferation of MCF7, PC3, or 1To whom correspondence should be addressed. E-mail: [email protected]. LnCaP cancer cells (18, 19). Rsk also inhibits apoptosis in PC3 This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. prostate cancer cells (21). 1073/pnas.1306328110/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1306328110 PNAS | December 17, 2013 | vol. 110 | no. 51 | 20605–20610 Downloaded by guest on October 2, 2021 cells refractory to the checkpoint-inhibitory effects of Rsk. This suggest that Rsk might inhibit the DSB checkpoint in PC3 prostate finding is consistent with a previous study showing that phosphor- cancer cells. To examine this possibility further, we stained PC3 ylation on Mre11 is mostly inhibitory (32). Taken together, these cells for γ-H2AX, a downstream target of ATM. As shown in Fig. findings identify a locus of checkpoint regulation by Rsk and 1B, PC3 cells treated with SL0101 before NCS treatment dis- support the idea of targeting Rsk for therapeutic benefit. played greatly increased γH2AX staining. These data strongly suggest that high Rsk activity can suppress ATM-dependent G2/M Results checkpoint signaling. Prostate Cancer Cells with High Levels of Endogenous Rsk Are Resistant Although it has been reported that inhibiting ATM may en- hance G2/M accumulation (33), inhibiting ATM decreased the to DSBs. Rsk is highly expressed in many prostate cancer cell lines, B including PC3 and LnCaP cells, which appear to be highly de- G2/M population in the cell lines we used (Fig S1 ). This result pendent on Rsk activity for growth and survival (19). We hy- also is consistent with other published studies (34, 35). To determine if Rsk is sufficient to confer resistance to DSB- pothesized that Rsk might modulate the response of these cells induced G2/M arrest, we overexpressed constitutively active Rsk2 to DNA damage-induced checkpoint function. To evaluate this in 293T cells, which have much lower endogenous levels of Rsk hypothesis, we analyzed cell-cycle progression after DSB induction than PC3 cells. As shown in Fig. 1C, Rsk-expressing cells were in PC3 cells that endogenously express twice the level of Rsk considerably less sensitive to DNA damage than control cells. To protein found in normal prostate tissue (19). Cells were arrested at demonstrate G2/M checkpoint suppression, directly, we synchro- G1/S using double thymidine block and 4 h after release were nized HeLa cells in G1/S phase by double thymidine block and treated with PMA and/or SL0101, followed by NCS to induce treated them 4 h after release with PMA or SL0101 for 30 min and DSBs during the G2 phase. After drugs were washed away, cells with NCS for an additional 30 min. Three or five hours later, cells were incubated in fresh media for 16 h before DNA contents were were stained with anti–phospho-Histone H3 (PHH3) antibody. As analyzed. As shown in Fig. 1A, cotreatment of cells with SL0101 shown in Fig. S1C, NCS significantly reduced the number of pHH3- and NCS resulted in much more robust G2/M arrest than seen positive cells by arresting cells in G2 phase.
Load more

Recommended publications
  • The Functions of DNA Damage Factor RNF8 in the Pathogenesis And
    Int. J. Biol. Sci. 2019, Vol. 15 909 Ivyspring International Publisher International Journal of Biological Sciences 2019; 15(5): 909-918. doi: 10.7150/ijbs.31972 Review The Functions of DNA Damage Factor RNF8 in the Pathogenesis and Progression of Cancer Tingting Zhou 1, Fei Yi 1, Zhuo Wang 1, Qiqiang Guo 1, Jingwei Liu 1, Ning Bai 1, Xiaoman Li 1, Xiang Dong 1, Ling Ren 2, Liu Cao 1, Xiaoyu Song 1 1. Institute of Translational Medicine, China Medical University; Key Laboratory of Medical Cell Biology, Ministry of Education; Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, Shenyang, Liaoning Province, China 2. Department of Anus and Intestine Surgery, First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China Corresponding authors: Xiaoyu Song, e-mail: [email protected] and Liu Cao, e-mail: [email protected]. Key Laboratory of Medical Cell Biology, Ministry of Education; Institute of Translational Medicine, China Medical University; Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, Shenyang, Liaoning Province, 110122, China. Tel: +86 24 31939636, Fax: +86 24 31939636. © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2018.12.03; Accepted: 2019.02.08; Published: 2019.03.09 Abstract The really interesting new gene (RING) finger protein 8 (RNF8) is a central factor in DNA double strand break (DSB) signal transduction.
    [Show full text]
  • 2. the MRN Complex
    reviewreview The MRN complex: coordinating and mediating the response to broken chromosomes Michael van den Bosch, Ronan T.Bree & Noel F. Lowndes+ Genome Stability Laboratory, National University of Ireland, Galway, Ireland The MRE11–RAD50–NBS1 (MRN) protein complex has been linked mechanisms by modification and activation of specific repair factors. to many DNA metabolic events that involve DNA double-stranded Alternatively, if the damage is irreparable or an excessive number of breaks (DSBs). In vertebrate cells, all three components are encoded lesions is present, checkpoint signalling is also required to induce by essential genes, and hypomorphic mutations in any of the human apoptotic cell death. The two main mechanisms of DSB repair are genes can result in genome-instability syndromes. MRN is one of the non-homologous end joining (NHEJ) and homologous recombination first factors to be localized to the DNA lesion, where it might initially (HR; Barnes, 2001; van den Bosch et al., 2002). The malfunction have a structural role by tethering together, and therefore stabiliz- of these mechanisms can result in the fusion of DNA ends that were ing, broken chromosomes. This suggests that MRN could function as originally distant from one another in the genome, which generates a lesion-specific sensor. As well as binding to DNA, MRN has other chromosomal rearrangements such as inversions, translocations and roles in both the processing and assembly of large macromolecular deletions. The resulting disruption of gene expression can perturb complexes (known as foci) that facilitate efficient DSB responses. normal cell proliferation or result in cell death. Recently, a novel mediator protein, mediator of DNA damage checkpoint protein 1 (MDC1), was shown to co-immunoprecipitate The MRN complex and the repair of DNA damage with the MRN complex and regulate MRE11 foci formation.
    [Show full text]
  • ABSTRACT Title of Document: the FUNCTION of MRN (MRE11-RAD50- NBS1) COMPLEX DURING WRN (WERNER) FACILITATED ATM (ATAXIA- TELANGI
    ABSTRACT Title of Document: THE FUNCTION OF MRN (MRE11-RAD50- NBS1) COMPLEX DURING WRN (WERNER) FACILITATED ATM (ATAXIA- TELANGIECTASIA MUTATED) ACTIVATION Junhao Ma, Master of Science, 2009 Directed By: Assistant Professor, Dr. Wen-Hsing Cheng, Department of Nutrition and Food Science WRN (Werner) protein is a member of the RecQ family showing helicase and exonuclease activity. WRN protein may lose function upon mutation and causes Werner syndrome (WS) which is an autosomal recessive, cancer-prone and premature aging disease. ATM (Ataxia-Telangiectasia mutated) protein initiates a signaling pathway in response to DNA double strand breaks (DSBs). Genomic disorder ataxia- telangiectasia (A-T) is associated with defective ATM. WRN protein is involved in ATM pathway activation when cells are exposed to DSBs associated with replication fork collapse. Because the Mre11-Rad50-Nbs1 (MRN) complex, a sensor of DSBs, is known to interact with WRN and ATM, we investigated whether the MRN complex mediates the WRN-dependent ATM pathway activation. In this study, we employed short-hairpin RNA to generate WRN- and Nbs1-deficient U-2 OS (osteosarcoma) cells. Cells were treated with clastogens which induce collapsed replication forks, thus provided proof for whether WRN facilitates ATM activation via MRN complex. This study serves as a basis for future investigation on the correlation between ATM, MRN complex and WRN, which will ultimately help understand the mechanism of aging and cancer. THE FUNCTION OF MRN (MRE11-RAD50-NBS1) COMPLEX DURING WRN (WERNER) FACILITATED ATM (ATAXIA-TELANGIECTASIA MUTATED) ACTIVATION By Junhao Ma Thesis submitted to the Faculty of the Graduate School of the University of Maryland, College Park, in partial fulfillment of the requirements for the degree of Master of Science 2009 Advisory Committee: Professor Wen-Hsing Cheng, Chair Professor Mickey Parish Professor Liangli (Lucy) Yu © Copyright by Junhao Ma 2009 Dedication To my daughter Aimi, my wife Yangming, my father and mother.
    [Show full text]
  • Abnormal Function of Telomere Protein TRF2 Induces Cell Mutation and the Effects of Environmental Tumor‑Promoting Factors (Review)
    ONCOLOGY REPORTS 46: 184, 2021 Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor‑promoting factors (Review) ZHENGYI WANG1‑3 and XIAOYING WU4 1Good Clinical Practice Center, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610071; 2Institute of Laboratory Animals of Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital; 3Yinglongwan Laboratory Animal Research Institute, Zhonghe Community, High‑Tech Zone, Chengdu, Sichuan 610212; 4Ministry of Education and Training, Chengdu Second People's Hospital, Chengdu, Sichuan 610000, P.R. China Received March 24, 2021; Accepted June 14, 2021 DOI: 10.3892/or.2021.8135 Abstract. Recent studies have found that somatic gene muta‑ microenvironment, and maintains the stemness characteris‑ tions and environmental tumor‑promoting factors are both tics of tumor cells. TRF2 levels are abnormally elevated by a indispensable for tumor formation. Telomeric repeat‑binding variety of tumor control proteins, which are more conducive factor (TRF)2 is the core component of the telomere shelterin to the protection of telomeres and the survival of tumor cells. complex, which plays an important role in chromosome In brief, the various regulatory mechanisms which tumor cells stability and the maintenance of normal cell physiological rely on to survive are organically integrated around TRF2, states. In recent years, TRF2 and its role in tumor forma‑ forming a regulatory network, which is conducive to the tion have gradually become a research hot topic, which has optimization of the survival direction of heterogeneous tumor promoted in‑depth discussions into tumorigenesis and treat‑ cells, and promotes their survival and adaptability.
    [Show full text]
  • Post-Translational Modification of MRE11: Its Implication in DDR And
    G C A T T A C G G C A T genes Review Post-Translational Modification of MRE11: Its Implication in DDR and Diseases Ruiqing Lu 1,† , Han Zhang 2,† , Yi-Nan Jiang 1, Zhao-Qi Wang 3,4, Litao Sun 5,* and Zhong-Wei Zhou 1,* 1 School of Medicine, Sun Yat-Sen University, Shenzhen 518107, China; [email protected] (R.L.); [email protected] (Y.-N.J.) 2 Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College; Kunming 650118, China; [email protected] 3 Leibniz Institute on Aging–Fritz Lipmann Institute (FLI), 07745 Jena, Germany; zhao-qi.wang@leibniz-fli.de 4 Faculty of Biological Sciences, Friedrich-Schiller-University of Jena, 07745 Jena, Germany 5 School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen 518107, China * Correspondence: [email protected] (L.S.); [email protected] (Z.-W.Z.) † These authors contributed equally to this work. Abstract: Maintaining genomic stability is vital for cells as well as individual organisms. The meiotic recombination-related gene MRE11 (meiotic recombination 11) is essential for preserving genomic stability through its important roles in the resection of broken DNA ends, DNA damage response (DDR), DNA double-strand breaks (DSBs) repair, and telomere maintenance. The post-translational modifications (PTMs), such as phosphorylation, ubiquitination, and methylation, regulate directly the function of MRE11 and endow MRE11 with capabilities to respond to cellular processes in promptly, precisely, and with more diversified manners. Here in this paper, we focus primarily on the PTMs of MRE11 and their roles in DNA response and repair, maintenance of genomic stability, as well as their Citation: Lu, R.; Zhang, H.; Jiang, association with diseases such as cancer.
    [Show full text]
  • Role of Nibrin in Advanced Ovarian Cancer
    BREAKING FROM THE LAB Role of nibrin in advanced ovarian cancer A. González-Martin1, M. Aracil2, C.M. Galmarini2, F. Bellati3 Abstract Nibrin is a protein coded by the NBS1 gene which plays a crucial role in DNA repair and cell cycle checkpoint signalling. Nibrin apparently plays two different roles in ovarian cancer. Firstly, mutation in NBS1 can be implicated in ovarian tumorigenesis. Secondly, in invasive tumours, high expression of nibrin mRNA or protein seems to correlate with a worse prognosis and worse response to treatment. All of these data indicate that nibrin could be involved in the clinical outcome of ovarian cancer patients and that it could be a potential target for this disease. Key words: nibrin, ovarian cancer, trabectedin Introduction onstrated that nibrin interacts with phosphorylated histone Nibrin (NBN, NBS1) is the product of the NBS1 gene lo- g-H2AX at sites of DSBs favouring the recruitment of the cated in locus 8q21.3. This protein is a 754 amino acid MRN complex. In addition, nibrin activates the cell cycle polypeptide that acts together with MRE11 and RAD50 checkpoint and downstream molecules, including p53 and proteins to form the MRN complex. The MRN complex is BRCA1 [9]. involved in the recognition and the repair of double strand breaks (DSBs) through homologous recombination (HR) Mutations of the NBS1 gene and non-homologous end-joining (NHEJ) pathways. It and tumorigenesis also activates the signalling cascades that lead to cell cy- Mutations of the NBS1 gene have functional conse- cle control in response to DNA damage (Figure 1) [1]. Ni- quences for the biological activity of nibrin.
    [Show full text]
  • High Expression of MRE11–RAD50–NBS1 Is Associated with Poor
    ANTICANCER RESEARCH 36 : 5237-5248 (2016) doi:10.21873/anticanres.11094 High Expression of MRE11–RAD50–NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer BOLAG ALTAN 1,2* , TAKEHIKO YOKOBORI 1,3* , MUNENORI IDE 4, TUYA BAI 1, TORU YANOMA 1, AKIHARU KIMURA 1, NORIMICHI KOGURE 1, MASAKI SUZUKI 1, PINJIE BAO 1, ERITO MOCHIKI 5, KYOICHI OGATA 1, TADASHI HANDA 4, KYOICHI KAIRA 2, MASAHIKO NISHIYAMA 3, TAKAYUKI ASAO 6, TETSUNARI OYAMA 4 and HIROYUKI KUWANO 1 Departments of 1General Surgical Science, 2Oncology Clinical Development, 3Molecular Pharmacology and Oncology, and 4Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma, Japan; 5Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan; 6Big Data Center for Intergrative Analysis, Gunma University Initiative for Advance Research, Maebashi, Gunma, Japan Abstract. Background: The MRN complex of meiotic and RAD50 were independent predictors of surgical recombination 11 (MRE11), DNA repair protein Rad50 resection after chemotherapy. Conclusion: The high (RAD50) and Nijmegen breakage syndrome 1 (NBS1) expression of MRN complex constituents could be a predictor proteins coordinate the detection and repair of DNA double- for poor prognosis and chemoresistance in GC. strand breaks (DSBs). DNA DSB repair-dependent chemoresistance likely has an effect on the treatment of Gastric cancer (GC) is the fifth most common cancer human cancer. Materials and Methods: We investigated the worldwide, with nearly one million diagnoses annually (1). expression of MRN complex in human gastric cancer (GC) Treatment with aggressive and adjuvant chemotherapy in tissues using immunohistochemistry and analyzed its clinical advanced GC has led to improved survival rates, but the significance and prognostic relevance.
    [Show full text]
  • Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex
    2024 Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex Huan-Ming Hsu,1,2,3 Hui-Chun Wang,2 Sou-Tong Chen,6 Giu-Cheng Hsu,4 Chen-Yang Shen,2,5 and Jyh-Cherng Yu3 1Graduate Institute of Medical Sciences, National Defense Medical Center; 2Institute of Biomedical Sciences, Academia Sinica; Departments of 3Surgery and 4Radiology, Tri-Service General Hospital; 5Life Science Library, Academia Sinica, Taipei, Taiwan; and 6Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan Abstract The evolutionarily conserved Mre11-Rad50-Nbs1 observations that (a) one single-nucleotide polymor- (MRN) complex, consisting of proteins encoded by phism in Nbs1 was significantly associated with breast the genes Mre11, Rad50, and Nbs1, was recently shown cancer risk, and a trend toward an increased risk of to play a crucial role in DNA double-strand break developing breastcancer was found in women harbor- (DSB) repair by recruiting the nuclear protein kinase ing a greater number of putative high-risk genotypes of ataxia telangiectasia mutated to DSB sites, leading to MRN genes (an adjusted odds ratio of 1.25 for each activation of this DNA repair network. Given the fact additional putative high-risk genotype; 95% confidence that carriers of defective mutation and polymorphic interval, 1.10-1.44); (b) this association between risk and variants of ataxia telangiectasia mutated are athigher the number of putative high-risk genotypes was risk of developing breastcancer, we hypothesizeda stronger and more significant in women thought to be role of the MRN genes in determining breast cancer more susceptible to estrogen, i.e., those with no history susceptibility.
    [Show full text]
  • Mutational Analysis of Thirty-Two Double-Strand DNA Break Repair Genes in Breast and Pancreatic Cancers
    Priority Report Mutational Analysis of Thirty-two Double-Strand DNA Break Repair Genes in Breast and Pancreatic Cancers Xianshu Wang,1 Csilla Szabo,1 Chiping Qian,3 Peter G. Amadio,1 Stephen N. Thibodeau,1 James R. Cerhan,2 Gloria M. Petersen,2 Wanguo Liu,3 and Fergus J. Couch1 Departments of 1Laboratory Medicine and Pathology and 2Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota and 3Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, Louisiana Abstract that mutations in other DNA damage repair genes may predispose and/or contribute to breast cancer. Similarly, the recent discovery Inactivating mutations in several genes that encode compo- BRCA2, FANCC FANCG nents of the DNA repair machinery have been associated with that mutations in , and (2, 11, 12) are an increased risk of breast cancer. To assess whether associated with pancreatic cancer suggests that mutations in other alterations in other DNA repair genes contribute to breast repair genes may contribute to pancreatic cancer risk. To identify cancer and to further determine the relevance of these genes other DNA repair genes associated with breast and pancreatic to pancreatic cancer, we performed mutational analysis of 32 cancer, we performed a mutation screen of the coding regions of 32 genes involved in DSB signaling and repair in 38 breast tumors, DNA double-strand break repair genes in genomic DNA from BRCA1/ BRCA1/ 48 pancreatic tumors, and germline DNA from 10 non- 38 breast tumors, 48 pancreatic tumors, and 10 non- BRCA2 BRCA2 hereditary breast cancer patients. A total of 494 coding hereditary breast cancer patients.
    [Show full text]
  • ATM: Main Features, Signaling Pathways, and Its Diverse Roles in DNA Damage Response, Tumor Suppression, and Cancer Development
    G C A T T A C G G C A T genes Review ATM: Main Features, Signaling Pathways, and Its Diverse Roles in DNA Damage Response, Tumor Suppression, and Cancer Development Liem Minh Phan 1,* and Abdol-Hossein Rezaeian 2,* 1 Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA 2 Department of Drug Discovery & Biomedical Sciences, College of Pharmacy, The University of South Carolina, Columbia, SC 29208, USA * Correspondence: [email protected] (L.M.P.); [email protected] (A.-H.R.) Abstract: ATM is among of the most critical initiators and coordinators of the DNA-damage response. ATM canonical and non-canonical signaling pathways involve hundreds of downstream targets that control many important cellular processes such as DNA damage repair, apoptosis, cell cycle arrest, metabolism, proliferation, oxidative sensing, among others. Of note, ATM is often considered a major tumor suppressor because of its ability to induce apoptosis and cell cycle arrest. However, in some advanced stage tumor cells, ATM signaling is increased and confers remarkable advantages for cancer cell survival, resistance to radiation and chemotherapy, biosynthesis, proliferation, and metastasis. This review focuses on addressing major characteristics, signaling pathways and especially the diverse roles of ATM in cellular homeostasis and cancer development. Citation: Phan, L.M.; Rezaeian, A.-H. ATM: Main Features, Signaling Keywords: ATM; cancer; DNA damage repair; DNA damage response; oxidative sensing; autophagy; Pathways, and Its Diverse Roles in hypoxia; pexophagy; mitophagy; cellular homeostasis DNA Damage Response, Tumor Suppression, and Cancer Development. Genes 2021, 12, 845.
    [Show full text]
  • Human RAD50 Deficiency: Confirmation of a Distinctive Phenotype
    Received: 24 November 2019 Revised: 24 February 2020 Accepted: 9 March 2020 DOI: 10.1002/ajmg.a.61570 ORIGINAL ARTICLE Human RAD50 deficiency: Confirmation of a distinctive phenotype Aviël Ragamin1 | Gökhan Yigit2 | Kristine Bousset3 | Filippo Beleggia4 | Frans W. Verheijen1 | Marie-Claire Y. de Wit5,6 | Tim M. Strom7,8 | Thilo Dörk3 | Bernd Wollnik2,9 | Grazia M. S. Mancini1,6 1Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Abstract Netherlands DNA double-strand breaks (DSBs) are highly toxic DNA lesions that can lead to chro- 2 Institute of Human Genetics, University mosomal instability, loss of genes and cancer. The MRE11/RAD50/NBN (MRN) com- Medical Center Göttingen, Göttingen, Germany plex is keystone involved in signaling processes inducing the repair of DSB by, for 3Department of Gynecology and Obstetrics, example, in activating pathways leading to homologous recombination repair and Hannover Medical School, Hannover, Germany nonhomologous end joining. Additionally, the MRN complex also plays an important 4Clinic I of Internal Medicine, University Hospital Cologne, Cologne, Germany role in the maintenance of telomeres and can act as a stabilizer at replication forks. 5Department of Child Neurology, Sophia Mutations in NBN and MRE11 are associated with Nijmegen breakage syndrome Children's Hospital, Erasmus MC University (NBS) and ataxia telangiectasia (AT)-like disorder, respectively. So far, only one single Medical Center, Rotterdam, Netherlands 6ENCORE Expertise Center for patient with biallelic loss of function variants in RAD50 has been reported presenting Neurodevelopmental Disorders, Rotterdam, with features classified as NBS-like disorder. Here, we report a long-term follow-up The Netherlands of an unrelated patient with facial dysmorphisms, microcephaly, skeletal features, 7Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany and short stature who is homozygous for a novel variant in RAD50.
    [Show full text]
  • The Role of the MRN Complex in Cancer – F Zeilstra
    The Role of the MRN Complex in Cancer – F Zeilstra The Role of the MRN Complex in Cancer F Zeilstra. University Medical Center Groningen, Groningen, The Netherlands. July 12th 2010. Exogenous or endogenous DNA damaging agents can threaten the genomic integrity of a cell. Therefore, there are cell cycle checkpoints to prevent passing on genomic instability as well as DNA repair mechanisms. Two major double-strand break repair mechanisms exist; non-homologous end joining (NHEJ) and homologous recombination (HR). The MRN complex is involved in both processes and especially plays a pivotal role in HR together with ataxia telangiectasia mutated (ATM). Mutations in the complex or the ATM gene cause severe disorders, sensitivity to radiation and predisposition to several types of cancer because of the failure to repair DSBs. However, the protein complex also appears to be an attractive target for anticancer therapies due to its involvement in both repair machinery. Keywords: Nijmegen breakage syndrome, NBS, NBN, RAD50, MRE11, ATM, ATLD. Introduction simply used as a template to fix the break, while DSBs are more complex and can All organisms have several mechanisms to cause rearrangements in the maintain the integrity of their genome for chromosomes, cell death, cell senescence generations. These include cell cycle or tumors if not properly repaired [Khanna checkpoints during DNA replication and and Jackson, 2001; Van Gent et al, 2001; mitosis as well as DNA damage repair. Helmink et al, 2009; Shiloh 2003; Rouse The latter is important because genomes and Jackson, 2002; Wyman and Kanaar, are subjected to various types of 2006]. exogenous or endogenous DNA damaging agents, like radiation or reactive radicals, There are two major DSB repair respectively [Khanna and Jackson, 2001; mechanisms: non-homologous end joining Shen and Nickoloff, 2007; Paques and (NHEJ) and homologous recombination Haber, 1999; Franco et al, 2006; (HR) with very distinct differences and little Chaudhuri et al, 2007; Murnane, 2006; overlap (Fig.
    [Show full text]